Swiss agrichemicals and seeds group Syngenta generated double-digit growth in the second quarter ahead of the Chinese-owned company’s planned flotation by year’s end.
Sales increased 24 per cent to $9.2 billion (€9.2 billion) while earnings before interest, tax, depreciation and amortisation (Ebitda) rose 39 per cent to $1.7 billion, the company said, citing launches of new products and services, increased productivity and prices that offset higher costs.
All business units achieved double-digit sales growth in the quarter and the first half of 2022, it said. Its Ebitda margin improved by 1.1 percentage points from a year earlier to 19.5 per cent in the first half of 2022.
Syngenta Group had increased first-quarter sales by 26 per cent to $8.9 billion as farmers bought seeds and sprays early to avoid possible shortages, the company said in April. Core profit rose 25 per cent to $1.9 billion in the first three months.
If you worked in the UK there is an opportunity to boost your pension
Trump trade - a quick guide to US tariff plans
Declining birth rate means there will be fewer people of working age to support the growing number of pensioners
‘The motor industry is changing, but we’re here to stay’: BMW Ireland’s boss on EVs, innovation and the road ahead
Syngenta, which competes with US company Corteva and Germany’s BASF and Bayer, was bought in 2017 for $43 billion by ChemChina, which was folded into Sinochem Holdings Corp last year. The parent company plans to keep a majority stake after the $10 billion flotation, which is expected to value Syngenta at around $50 billion. — Reuters
